| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Epizyme, Inc. | Director | Stock Option (Right to Buy) | 41,006 | $22,963 | $0.5600 | 17 May 2022 | Direct |
| Epizyme, Inc. | Director | Common Stock, par value $0.0001 | 0 | $1.41 | 12 Aug 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000089924322028868-beveridge-roy-a-2022-08-12 | Epizyme, Inc. | 12 Aug 2022 | 2 | $0 | 4 | Director | 16 Aug 2022, 18:58 |
| /report/000089924322025017-beveridge-roy-a-2022-06-30 | Epizyme, Inc. | 30 Jun 2022 | 1 | +$13,124 | 4 | Director | 05 Jul 2022, 17:06 |
| /report/000089924322018808-beveridge-roy-a-2022-05-17 | Epizyme, Inc. | 17 May 2022 | 2 | $0 | 4 | Director | 19 May 2022, 16:20 |
| /report/000089924322013155-beveridge-roy-a-2022-03-31 | Epizyme, Inc. | 31 Mar 2022 | 1 | +$13,125 | 4 | Director | 01 Apr 2022, 17:31 |
| /report/000089924321045212-beveridge-roy-a-2021-11-16 | Epizyme, Inc. | 16 Nov 2021 | 2 | $0 | 4 | Director | 18 Nov 2021, 07:22 |
| /report/000089924321045208-beveridge-roy-a-2021-11-16 | Epizyme, Inc. | 16 Nov 2021 | 0 | $0 | 3 | Director | 18 Nov 2021, 07:16 |